BSE filing, NSE: MOTILALOFS. Summary written from the filing by ALFA Finder's alert engine.
Motilal Oswal Financial Services Ltd: key numbers
- Share price
- ₹986.10
- Market cap
- ₹59,460 Cr
- Revenue (annual)
- ₹9,374 Cr
- Net profit (annual)
- ₹1,869 Cr
- P/E (TTM)
- 30.0×Sector 19.7×
- Promoter holding
- 66.71%-0.49% QoQ
- FII holding
- 6.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Motilal Oswal Financial Services Ltd
All →Motilal Oswal Financial Services Other Announcement
Motilal Oswal Financial Services certifies utilisation of proceeds from listed Commercial Papers issued in the quarter ended September 30, 2026, and adherence to listing conditions. This is a periodic regulatory compliance certificate.
Motilal Oswal Financial Services Management Change
Motilal Oswal Financial Services appointed Janak Dalal as Senior Management Personnel, effective October 29, 2026. He brings about three decades of custody and investment banking experience.
Motilal Oswal Financial Services Employee Stock Options
Motilal Oswal Financial Services granted 2,20,000 stock options to eligible employees under its ESOP Scheme X. No exercise price or monetary value is disclosed.
Motilal Oswal Financial Services Investor Presentation: Key Takeaways
Q2FY27 Operating PAT ₹718 Cr (+29% YoY); H1FY27 Total PAT ₹2,583 Cr (+51%). Asset Management now largest profit contributor at 43%; ARR 66% of revenue.
- Call
- Guides 20% growth
Motilal Oswal Financial Services Results Update
Motilal Oswal reported Q2FY27 Operating PAT of Rs 718 Crore, up 29% YoY. Record H1 Total PAT was Rs 2,583 Crore, up 51%.
Motilal Oswal Financial Services Debt & Borrowing: ₹5.43 Cr
Motilal Oswal Financial Services paid Rs. 5.43 Crore interest on its Series (2026-27)/2 secured NCDs on time. The payment is routine debt servicing with no reported non-payment.
- Value
- ₹5.43 Cr
Other financial results announcements
All →Strides Pharma Science Q2 FY27 Results: Net Profit ₹134.1 Cr, Up 2.0% YoY
Strides Pharma Science Ltd reported revenue from operations of ₹1,430 Cr (+17.1% YoY) and net profit of ₹134.1 Cr (+2.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹134.1 Cr · +2.0% YoY
Fusion Klassroom Edutech H1 FY27 Results: Net Profit ₹4.8 Cr, Up 23.1% YoY
Fusion Klassroom Edutech Ltd reported revenue from operations of ₹14.9 Cr (+21.1% YoY) and net profit of ₹4.8 Cr (+23.1% YoY) for H1 FY27.
- Key figure
- Net profit ₹4.8 Cr · +23.1% YoY
Deepak Nitrite Q2 FY27 Results: Net Profit ₹397.7 Cr, Up 234.8% YoY
Deepak Nitrite Ltd reported revenue from operations of ₹3,076 Cr (+61.8% YoY) and net profit of ₹397.7 Cr (+234.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹397.7 Cr · +234.8% YoY
Asset Reconstruction Company (India) Q2 FY27 Results: Net Profit ₹157.8 Cr, Up 55.8% YoY
Asset Reconstruction Company (India) Ltd reported revenue from operations of ₹276.5 Cr (+30.7% YoY) and net profit of ₹157.8 Cr (+55.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹157.8 Cr · +55.8% YoY
Capital Small Finance Bank Q2 FY27 Results: Net Profit ₹45.6 Cr, Up 30.7% YoY
Capital Small Finance Bank Ltd reported revenue from operations of ₹300.8 Cr (+17.3% YoY) and net profit of ₹45.6 Cr (+30.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹45.6 Cr · +30.7% YoY
Sanofi India Q2 FY27 Results: Net Profit ₹116.7 Cr, Up 53.6% YoY
Sanofi India reported unaudited Q3 and nine-month results to 30 September 2026, with profit before tax up 22% to INR 158 crore. It also declared an interim dividend of Rs 75 per share with a record date of 5 November 2026.
- Key figure
- Net profit ₹116.7 Cr · +53.6% YoY